Logo
x

Search

Subscribe Now

inflammatory diseases

Sanofi Collaborates with C4XD for an Oral Therapy to Treat Inflammatory Diseases

Sanofi Collaborates with C4XD for an Oral Therapy to Treat Inflammatory Diseases

  • April 13, 2021
Pfizer Initiates Clinical Study of Eighth Candidate Emerges Under the Collaboration with Sosei Heptares

Pfizer Initiates Clinical Study of Eighth Candidate Emerges Under the Collaboration with Sosei Heptares

  • September 28, 2020
Roche Acquires Inflazome for ~$450M

Roche Acquires Inflazome for ~$450M

  • September 21, 2020
AbbVie Signs an Exclusive Research and Option to License Agreement with Sosei Heptares Targeting Inflammatory and Autoimmune Diseases

AbbVie Signs an Exclusive Research and Option to License Agreement with Sosei Heptares Targeting Inflammatory and Autoimmune Disea...

  • June 26, 2020
Amgen Launches Amgevita (biosimilar- adalimumab) for the Treatment of Inflammatory Diseases in Brazil

Amgen Launches Amgevita (biosimilar- adalimumab) for the Treatment of Inflammatory Diseases in Brazil

  • February 3, 2020
Arena Signs a Multi-Year Agreement with Beacon Discovery to Develop Therapies for Immune and Inflammatory Diseases

Arena Signs a Multi-Year Agreement with Beacon Discovery to Develop Therapies for Immune and Inflammatory Diseases

  • January 3, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.